Welcoming Dr. Eyad Elkord to Cancer Immunology Connect
Published at 19 August 2024
We warmly welcome Dr. Eyad Elkord to the Scifiniti community. We are confident that under his expert leadership, Cancer Immunology Connect will not only thrive but also establish itself as a leading journal in the field. Dr. Elkord’s extensive experience and distinguished reputation will undoubtedly guide this journal toward excellence. We greatly appreciate his commitment to our mission and look forward to his valuable contributions to our team.